Archives ipo

by in
Entry Author Date Location
With $550M Fund, Deerfield Management Tackles Early Stage Biotech 07/28/15 New York
Wisconsin Roundup: Capital Midwest, Healthfinch, TAI, & More 07/28/15 Wisconsin
Seattle Roundup: Acquisitions by Zillow, TUNE, Remitly, & More 07/24/15 Seattle
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
“Boston’s Life Science Disruptors” to Share Their Stories on Sept. 30 07/23/15 Boston
In Biotech, Everyone’s Going Public. What’s Your Excuse? 07/22/15 National
After $103M IPO, Rapid7 Stock Up in Early Trading 07/17/15 Boston
Texas Roundup: SailPoint, DEC, Neos, Sanofi, NASA & XPrize 07/17/15 Texas
Rapid7 Prices IPO at $16 Per Share as Cybersecurity Takes Center Stage 07/16/15 Boston
West Coast Biotech Roundup: Receptos, ProNAi, Protagonist & More 07/16/15 San Diego
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
EyeGate CEO: Valeant Deal Helps Company Avoid Mistakes of Past 07/15/15 Boston
Neos Therapeutics, Maker of ADHD Drug Delivery System, Files IPO 07/13/15 Texas
FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials 07/13/15 Boston
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
The Near Death, and Second Life, of Cerulean Pharma 07/13/15 Boston
EyeGate Deals Treatment Rights to Valeant to Pay for Clinical Trials 07/10/15 Boston
Epizyme Extends Celgene Cancer Deal for $10M Upfront 07/09/15 Boston
Tackling Sickle Cell, Global Blood Therapeutics Joins IPO Queue 07/08/15 San Francisco
Aimmune May Seek Up To $115M in IPO for Allergy Therapy Drug 07/07/15 San Francisco
FDA Cuts Limit on Esperion Cholesterol Drug, Considers Competitors 07/07/15 Detroit
Chiasma Seeks $75 Million and FDA Approval for Acromegaly Orphan Drug 07/06/15 Boston
West Coast Biotech Roundup: Juno, UCSD v. USC, Natera, LSDF & More 07/06/15 Seattle
Texas Roundup: SXSW, SparkCognition, TMCx, & Austin’s Biotech Scene 06/30/15 Texas
West Coast Biotech Roundup: Bock, Celladon, Arivale, Conkwest & More 06/26/15 San Diego
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
Bon Appetit: Seres And Its Microbiome Gut Treatment Notch $134M IPO 06/25/15 Boston
Retooled Catabasis Cuts Price, Upsizes to Grab $60M in IPO 06/25/15 Boston
The Decade Of The Brain: 25 Years Later 06/25/15 National
Houston Dares to Challenge the Bicoastal Model of Biotech Growth 06/23/15 Texas
Page 1 of 17 next page »